Biphosphonate Therapy, Risk of Fracture, and Sites of Bone Mineral Density Assessments in Kidney Transplantation
J Am Soc Nephrol
.
2019 May;30(5):905.
doi: 10.1681/ASN.2019010079.
Epub 2019 Mar 25.
Authors
Nahid Tabibzadeh
1
2
,
Nathalie Chavarot
2
,
Martin Flamant
3
2
,
Emmanuelle Vidal-Petiot
3
2
Affiliations
1
Renal Physiology, APHP Hôpital Bichat, Paris, France and
[email protected]
.
2
Université Paris Diderot, Inserm U1149, Paris, France.
3
Renal Physiology, APHP Hôpital Bichat, Paris, France and.
PMID:
30910935
PMCID:
PMC6493988
DOI:
10.1681/ASN.2019010079
No abstract available
Keywords:
kidney transplantation; mineral metabolism; renal osteodystrophy.
Publication types
Letter
Comment
MeSH terms
Bone Density
Chronic Kidney Disease-Mineral and Bone Disorder*
Fractures, Bone*
Humans
Kidney Transplantation*
Zoledronic Acid
Substances
Zoledronic Acid